p38MAPK信号通路与慢性阻塞性肺疾病.pdfVIP

3O9O 重庆医学2014年 8月第43卷第 23期 l9O breastcancer[J]．Oncogene，2008，27(34)：4657—4665． E12]MacdonaldME，AmbroseCM，DuyaoMP，eta1．Anovel [18]TayracM，EtcheverryA，AubryM，eta1．Integrativege— genecontaining a trinucleotide repeatthatisexpanded nome-wideanalysisrevealsarobustgenomicglioblastoma andunstableonHuntingtonsdiseasechromosomes[J]． signatureassociatedwithcopynumberdrivingchangesin Cell，1993，72(6)：971—983． geneexpression[J]．GenesChromosomesCancer，2009，48 [13]DesplatsPA，KassKE，GilmartinT，eta1．Selectivedeft— (1)：55—68． citsintheexpressionofstriatal—enrichedmRNAsinHun— [19]YingJ，L』H，SengTJ，eta1．Functionalepigeneticsidenti— tingtonsdisease[J]．JNeurochem，2006，96(3)：743—757． fiesaprotocadherinPCDH10asacandidatetumorsup— [14]ThomasEA．Striatalspecificityofgeneexpressiondys— pressorfornasopharyngeal，esophagealandmultipleother regulationinHuntingtonsdisease[J]．JNeurosciRes， carcinomaswith frequentmethylation[J]．Oncogene， 2006，84(6)：1151-1164． 2006，25(7)：1070—1080． [15]BecanovicK，PouladiMA，Lim RS，eta1．Transcriptiona1 [2O]HarukiS，ImotoI，KozakiK，eta1．Frequentsilencingof changesin Huntingtondiseaseidentified using genome— protocadherin 17，a candidate tumoursuppressorfore— wideexpressionprofilingandcross—platformanalysis[J]． sophagealsquamouscellcarcinoma[J]．Carcinogenesis， Hum MolGenet，2O1O，19(8)：1438—1452． 2010，31(6)：1027—1036． [16]HodgsonJG，AgopyanN，GutekunstCA，eta1．A YAC [21]ImotoI，IzumiH，YokoiS，eta1．Frequentsilencingofthe mousemodelforHuntington sdiseasewith full-length candidatetumorsuppressorPCDH20byepigeneticmeeh— mutant buntingtin，cytoplasm ic toxicity，and selective anism innon-small—celllungcancers[J]．CancerRes， striatalneurodegener